Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Heuser

Showing results (141-150 of 199) with videos related to

Pageof 20
Sort By:
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|July 26, 2005
A multicenter study about Neurobiology of Suicidal Behavior: design, development, and preliminary resultsThomas Bronisch, Jürgen Brunner, Brigitta Bondy, et al.
The Journal of Clinical Psychiatry|September 7, 2010
Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trialsFlorian Seemüller, Hans-Jürgen Möller, Michael Obermeier, et al.
Journal of Affective Disorders|January 18, 2006
Platelet 5-HT2A receptor binding and tryptophan availability in depression are not associated with recent history of suicide attempts but with personality traits characteristic for suicidal behaviorErik Lauterbach, Jürgen Brunner, Barbara Hawellek, et al.
Frontiers in Psychiatry|January 22, 2024
The impact of emotional dysregulation and comorbid depressive symptoms on clinical features, brain arousal, and treatment response in adults with ADHDJue Huang, Nicole Mauche, Eike Ahlers, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 5, 2022
The role of comorbid depressive symptoms on long-range temporal correlations in resting EEG in adults with ADHDJue Huang, Eike Ahlers, Holger Bogatsch, et al.
Biological Psychiatry|April 3, 2012
Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depressionGolo Kronenberg, Mustafa Balkaya, Vincent Prinz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 25, 2011
Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response?Rebecca Schennach-Wolff, Markus Jäger, Andreas Mayr, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 12, 2012
No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depressionRichard Musil, Peter Zill, Florian Seemüller, et al.
The International Journal of Neuropsychopharmacology|May 10, 2008
Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on SchizophreniaHans-Jürgen Möller, Michael Riedel, Markus Jäger, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 5, 2014
Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factorsFlorian Seemüller, Sebastian Meier, Michael Obermeier, et al.
Pageof 20

Showing results (141-150 of 199) with videos related to

Sort By:
Pageof 20
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|July 26, 2005
A multicenter study about Neurobiology of Suicidal Behavior: design, development, and preliminary resultsThomas Bronisch, Jürgen Brunner, Brigitta Bondy, et al.
The Journal of Clinical Psychiatry|September 7, 2010
Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trialsFlorian Seemüller, Hans-Jürgen Möller, Michael Obermeier, et al.
Journal of Affective Disorders|January 18, 2006
Platelet 5-HT2A receptor binding and tryptophan availability in depression are not associated with recent history of suicide attempts but with personality traits characteristic for suicidal behaviorErik Lauterbach, Jürgen Brunner, Barbara Hawellek, et al.
Frontiers in Psychiatry|January 22, 2024
The impact of emotional dysregulation and comorbid depressive symptoms on clinical features, brain arousal, and treatment response in adults with ADHDJue Huang, Nicole Mauche, Eike Ahlers, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 5, 2022
The role of comorbid depressive symptoms on long-range temporal correlations in resting EEG in adults with ADHDJue Huang, Eike Ahlers, Holger Bogatsch, et al.
Biological Psychiatry|April 3, 2012
Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depressionGolo Kronenberg, Mustafa Balkaya, Vincent Prinz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 25, 2011
Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response?Rebecca Schennach-Wolff, Markus Jäger, Andreas Mayr, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 12, 2012
No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depressionRichard Musil, Peter Zill, Florian Seemüller, et al.
The International Journal of Neuropsychopharmacology|May 10, 2008
Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on SchizophreniaHans-Jürgen Möller, Michael Riedel, Markus Jäger, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 5, 2014
Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factorsFlorian Seemüller, Sebastian Meier, Michael Obermeier, et al.
Pageof 20